Research now backs routinely offering pregnant women the mRNA COVID-19 vaccine

University of Auckland's research suggests the risk of severe outcomes from infection is significantly higher for pregnant women compared to the general population. 

Auckland: New Zealand and Australia will now routinely offer the Pfizer COVID-19 vaccine to women at any stage of pregnancy, following an update of vaccination advice. This comes as a University of Auckland's research suggests the risk of severe outcomes from infection is significantly higher for pregnant women compared to the general population. At the same time, data from pregnant women who have already been vaccinated around the world have shown no safety concerns associated with COVID-19 vaccines.